BRIEF published on 04/29/2025 at 14:05, 1 year 4 months ago Bausch Health Secures Health Canada Approval for Thermage FLX Thermage FLX Bausch Health Health Canada Aesthetic Technology Skin Tightening
PRESS RELEASE published on 04/29/2025 at 14:00, 1 year 4 months ago Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System Health Canada approves Thermage FLX, the latest non-invasive skin tightening system from Bausch Health's Solta Medical. Features enhanced comfort, smart technology, and versatile applications Thermage FLX Bausch Health Health Canada Skin Tightening Solta Medical
BRIEF published on 04/25/2025 at 14:05, 1 year 4 months ago Bausch Health Unveils Advanced Skin Resurfacing Technology at ASLMS 2025 Bausch Health Aesthetic Medicine Fraxel FTX™ Skin Resurfacing ASLMS 2025
BRIEF published on 04/25/2025 at 14:05, 1 year 4 months ago Bausch Health dévoile une technologie avancée de resurfaçage cutané à l'ASLMS 2025 Bausch Santé Médecine Esthétique Fraxel FTX™ ASLMS 2025 Resurfaçage De La Peau
PRESS RELEASE published on 04/25/2025 at 14:00, 1 year 4 months ago Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM) Bausch Health unveiled Fraxel FTX™, the next-gen skin resurfacing tech, at ASLMS 2025, Orlando. Dual-wavelength laser treats skin concerns with visible results & minimal downtime Bausch Health Laser Technology Skin Resurfacing ASLMS 2025 Fraxel FTX
BRIEF published on 04/22/2025 at 13:30, 1 year 4 months ago Bausch Health dépose un supplément à sa circulaire de sollicitation de procurations suite aux échanges d'actions d'Icahn Droits Des Actionnaires Bausch Santé Swaps D'actions Carl Icahn Déclaration De Procuration
BRIEF published on 04/22/2025 at 13:30, 1 year 4 months ago Bausch Health Files Supplement to Proxy Statement Amid Icahn's Equity Swaps Proxy Statement Bausch Health Shareholder Rights Equity Swaps Carl Icahn
PRESS RELEASE published on 04/22/2025 at 13:25, 1 year 4 months ago Bausch Health Announces Filing of Supplement to Proxy Statement Bausch Health updates Proxy Statement to disclose 24.6% common shares held by Carl Icahn. Company adopts shareholder rights plan agreement to prevent 'creeping' take-over bids Proxy Statement Bausch Health Update Shareholder Rights Plan Carl Icahn
BRIEF published on 04/17/2025 at 21:45, 1 year 5 months ago Bausch Health Prevails in U.S. District Court Case Bausch Health Norwich Pharmaceuticals XIFAXAN® FDA Ruling Teva Exclusivity
BRIEF published on 04/17/2025 at 21:45, 1 year 5 months ago Bausch Health l'emporte devant un tribunal de district américain Bausch Santé Norwich Pharmaceuticals XIFAXAN® Décision De La FDA Exclusivité Teva
Published on 09/21/2026 at 15:45, 3 hours 17 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 4 hours 42 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 4 hours 57 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 5 hours 2 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 5 hours 17 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 18:00, 1 hour 2 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 1 hour 17 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 1 hour 17 minutes ago Charwood Energy poursuit sur un rythme de croissance élevé. Chiffre d’affaires semestriel en hausse de +43 % à 5,6 M€.
Published on 09/21/2026 at 17:45, 1 hour 17 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 2 hours 2 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 43 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 43 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 1 hour 1 minute ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 1 hour 16 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 1 hour 16 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
